On best practices: The Institute of Medicine scheme for developing, validating, and demonstrating clinical utility of omics‐based diagnostic and predictive tests. Issue 11 (December 2013)

• Record Type: Journal Article
• Authors: Omenn, Gilbert S.; Sauer, Sascha
• Is Part Of: Proteomics. Volume 7:Issue 11/12(2013)
• Page Start: 748
• Page End: 755
• Publication Date: 2013-12
• Subjects: Proteomics -- Periodicals; 572.605
• DOI: 10.1002/prca.201300041
• Languages: English
• ISSNs: 1862-8346

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The Institute of Medicine of the US National Academy of Sciences issued a major report in 2012 that provides important guidance for the proteomics community for credible and transparent development of all kinds of omics‐based diagnostic and prognostic tests. The key elements are summarized here to provide a compass that can guide the studies emerging from many laboratories as reported in this special issue of <italic>Proteomics Clinical Applications</italic> on "Diagnostic Proteomics."</p> </abstract>